Application of deep learning to understand resilience to Alzheimer's disease pathology

被引:10
作者
Lee, Cecilia S. [1 ]
Latimer, Caitlin S. [2 ]
Henriksen, Jonathan C. [2 ]
Blazes, Marian [1 ]
Larson, Eric B. [3 ]
Crane, Paul K. [4 ]
Keene, C. Dirk [2 ]
Lee, Aaron Y. [1 ]
机构
[1] Univ Washington, Dept Ophthalmol, Box 359608,325 Ninth Ave, Seattle, WA 98104 USA
[2] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA
[3] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA
[4] Univ Washington, Dept Internal Med, Div Gen Internal Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
Adult Changes in Thought (ACT); Alzheimer' s disease; deep learning; neuropathology; phosphorylated tau; resilience; resistance; TDP‐ 43; NEUROPATHOLOGIC ASSESSMENT; IMAGE-ANALYSIS; AMYLOID-BETA; DEMENTIA; DIAGNOSIS; TDP-43; AGE;
D O I
10.1111/bpa.12974
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
People who have Alzheimer's disease neuropathologic change (ADNC) typically associated with dementia but not the associated cognitive decline can be considered to be "resilient" to the effects of ADNC. We have previously reported lower neocortical levels of hyperphosphorylated tau (pTau) and less limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) in the resilient participants compared to those with dementia and similar ADNC as determined by current NIA-AA recommendations using traditional semi-quantitative assessments of amyloid beta and pathological tau burden. To better understand differences between AD-dementia and resilient participants, we developed and applied a deep learning approach to analyze the neuropathology of 14 brain donors from the Adult Changes in Thought study, including seven stringently defined resilient participants and seven age-matched AD-dementia controls. We created two novel, fully automated deep learning algorithms to quantify the level of phosphorylated TDP-43 (pTDP-43) and pTau in whole slide imaging. The models performed better than traditional techniques for quantifying pTDP-43 and pTau. The second model was able to segment lesions staining for pTau into neurofibrillary tangles (NFTs) and tau neurites (neuronal processes positive for pTau). Both groups had similar quantities of pTau localizing to neurites, but the pTau burden associated with NFTs in the resilient group was significantly lower compared to the group with dementia. These results validate use of deep learning approaches to quantify clinically relevant microscopic characteristics from neuropathology workups. These results also suggest that the burden of NFTs is more strongly associated with cognitive impairment than the more diffuse neuritic tau commonly seen with tangle pathology and suggest that additional factors may underlie resilience mechanisms defined by traditional means.
引用
收藏
页数:10
相关论文
共 43 条
  • [1] [Anonymous], 1994, Diagnostic and statistical manual of mental disorders: DSM-IV
  • [2] Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
    Borgatti, Antonella
    Koopmeiners, Joseph S.
    Sarver, Aaron L.
    Winter, Amber L.
    Stuebner, Kathleen
    Todhunter, Deborah
    Rizzardi, Anthony E.
    Henriksen, Jonathan C.
    Schmechel, Stephen
    Forster, Colleen L.
    Kim, Jong-Hyuk
    Froelich, Jerry
    Walz, Jillian
    Henson, Michael S.
    Breen, Matthew
    Lindblad-Toh, Kerstin
    Oh, Felix
    Pilbeam, Kristy
    Modiano, Jaime F.
    Vallera, Daniel A.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2017, 16 (05) : 956 - 965
  • [3] Cognitive Resilience to Alzheimer's Disease Pathology in the Human Brain
    Bowles, Erin J. Aiello
    Crane, Paul K.
    Walker, Rod L.
    Chubak, Jessica
    LaCroix, Andrea Z.
    Anderson, Melissa L.
    Rosenberg, Dori
    Keene, C. Dirk
    Larson, Eric B.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (03) : 1071 - 1083
  • [4] Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
    Braak, Heiko
    Alafuzoff, Irina
    Arzberger, Thomas
    Kretzschmar, Hans
    Del Tredici, Kelly
    [J]. ACTA NEUROPATHOLOGICA, 2006, 112 (04) : 389 - 404
  • [5] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [6] Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy
    Chornenkyy, Yevgen
    Fardo, David W.
    Nelson, Peter T.
    [J]. LABORATORY INVESTIGATION, 2019, 99 (07) : 993 - 1007
  • [7] Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848
  • [8] The neuropathological diagnosis of Alzheimer's disease
    DeTure, Michael A.
    Dickson, Dennis W.
    [J]. MOLECULAR NEURODEGENERATION, 2019, 14 (01)
  • [9] Adjustment for Selection Bias in Observational Studies with Application to the Analysis of Autopsy Data
    Haneuse, S.
    Schildcrout, J.
    Crane, P.
    Sonnen, J.
    Breitner, J.
    Larson, E.
    [J]. NEUROEPIDEMIOLOGY, 2009, 32 (03) : 229 - 239
  • [10] He K, P IEEE C COMP VIS PA, P770, DOI [DOI 10.1109/CVPR.2016.90, 10.1109/CVPR.2016.90]